EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
Recruiting · NCT05979545 · Registry updated 2024-03-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics | Disease Attributes, Healthcare-Associated Pneumonia, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pneumonia, Ventilator-Associated, iatrogenic disease, lung disorder, nosocomial infection, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 4 | 2024-03-06 | NCT05979545 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Biomerieux inc | 1 |
| National University of Singapore | 97 |
| Pfizer | 431 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Kaohsiung Medical University Hospital | Kaohsiung City | Taiwan | 8 |
| Sunpasitthiprasong Hospital | Ubon Ratchathani | Thailand | 1 |
| Taichung Veterans General Hospital | Taichung | Taiwan | 2 |
| University Malaya Medical Centre | Kuala Lumpur | Malaysia | 3 |